Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4296368 | Journal de Chirurgie | 2008 | 5 Pages |
Abstract
In advanced-stage disease, lymph node involvement is an additional factor of poor prognosis correlating with increased tumor aggressivity. Optimal debulking resection of all visible tumor offers the best chance for a prolonged disease-free interval if patient condition permits and morbidity can be limited. Survival benefit for complete lymph node dissection has not been evaluated by randomized controlled trials; but several non-randomized studies and two long-term prospective trials have shown objective improvement in disease-free survival and improved quality of life when debulking surgery leaves no residual tumor larger than 1 cm.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
D. Salet-Lizée, S. Alsary,